HCV-positive organ donations could expand in era of direct acting antivirals
from MD Magazine
The American Society of Transplantation has reached consensus on how treatment of hepatitis C virus (HCV) with direct acting antivirals (DAAs) could enable organ transplantations to HCV naive recipients and potentially save the lives of many on transplant waitlists. Organ transplantation between HCV-positive donor and recipient is already accepted practice, and the consensus conference report lead author Josh Levitsky, MD, Professor of Medicine and Surgery, Northwestern University, Chicago, IL and co-authors explained the purpose of the January 2017 conference.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063